Aurora Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Aurora Financial Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$235K	Buy	+3,837	New	+$240K	0.17%	168

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aurora Financial Advisors's BMY Position: Q4 2017 in Review

Aurora Financial Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q4 2017: 3,837 shares worth $235K. The stake represents 0.17% of the portfolio and ranks #168 among its holdings.

1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Aurora Financial Advisors held 3,837 shares of Bristol-Myers Squibb worth $235K as of Q4 2017.
Bristol-Myers Squibb was a new Aurora Financial Advisors position in Q4 2017.
Bristol-Myers Squibb made up 0.17% of Aurora Financial Advisors's portfolio in Q4 2017, its #168 holding.
1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Aurora Financial Advisors's 13F filing for Q4 2017, filed 16 Mar 2018.